Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 246 results.
User Information
Export Records
  1. 1.   Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclib
  2. Pang, Ying; Li, Qi; Sergi, Zach; Yu, Guangyang; Kim, Olga; Lu, Peng; Chan, Marina; Sang, Xueyu; Wang, Herui; Ranjan, Alice; Robey, Robert W; Soheilian, Ferri; Tran,Bao; Núñez, Felipe J; Zhang, Meili; Song, Hua; Zhang, Wei; Davis, Dionne; Gilbert, Mark R; Gottesman, Michael M; Liu, Zhenggang; Thomas, Craig J; Castro, Maria G; Gujral, Taranjit S; Wu, Jing
  3. iScience. 2025, Apr 18; 28(4): 112283.
  1. 2.   CDK2 Inhibition Produces a Persistent Population of Polyploid Cancer Cells
  2. Tyutyunyk-Massey, Liliya; Chen,Zibo; Liu,Xiuxia; Kawakami, Masanori; Harned,Adam; Ng, Yeap; Harned,Adam; Okpechi,Samuel; Ogunlade,Blessing; Alfaro Mora,Yair; Weigert, Roberto; Narayan,Kedar; Liu,Xi; Dmitrovsky,Ethan
  3. JCI Insight. 2025, Apr 15;
  1. 3.   Histidine Tag-Specific PEGylation Improves the Circulating Half-Life of TIMP2
  2. Toor, Jack; Grabowska, Wiktoria R; Johnson, Adam L; Jones,Jane; Stetler-Stevenson, William G; Khalili, Hanieh; Peeney, David
  3. ACS Applied Bio Materials. 2025, Feb 21;
  1. 4.   Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350
  2. Joyce, M Gordon; Bu, Wei; Chen, Wei-Hung; Gillespie, Rebecca A; Andrews, Sarah F; Wheatley, Adam K; Tsybovsky,Yaroslav; Jensen, Jaime L; Stephens,Tyler; Prabhakaran, Madhu; Fisher, Brian E; Narpala, Sandeep R; Bagchi, Meghna; McDermott, Adrian B; Nabel, Gary J; Kwong, Peter D; Mascola, John R; Cohen, Jeffrey I; Kanekiyo, Masaru
  3. Immunity. 2025, Feb 11; 58(2): 295-308.e5. .
  1. 5.   Design, Synthesis and Biological Evaluation of 2-Phenyl Indole Analogues of OXi8006 as Colchicine Site Inhibitors of Tubulin Polymerization and Vascular Disrupting Agents
  2. Vairin, Rebecca; Tamminga, Caleb; Shi, Zhe; Borchardt, Christian; Jambulapati, Jayaram; Bai, Ruoli; Wanniarachchi, Hashini; Bueno, Lorena; Hamel,Ernest; Mason, Ralph P; Trawick, Mary Lynn; Pinney, Kevin G
  3. Bioorganic & Medicinal Chemistry. 2024, Nov 07; 118: 117981.
  1. 6.   Perplexing paradoxical reactions: navigating the complexity of protracted tuberculosis meningitis-a case report
  2. Gooding,Megan; Hammoud, Dima A; Epling, Brian; Rocco, Joseph; Laidlaw, Elizabeth; Kuriakose,Safia; Chaturvedi, Mansi; Galindo, Frances; Ma, Stella V; Mystakelis, Harry; Poole, April; Russo, Kelly; Shah, Maunank; Malone, Joseph L; Rupert,Adam; Sereti, Irini; Manion, Maura
  3. Frontiers in Immunology. 2024, Oct 31; 15: 1441945.
  1. 7.   Attenuating ribosome load improves protein output from mRNA by limiting translation-dependent mRNA decay
  2. Bicknell, Alicia A; Reid, David W; Licata, Marissa C; Jones, Adriana K; Cheng, Yi Min; Li, Mengying; Hsiao, Chiaowen Joyce; Pepin, Christopher S; Metkar, Mihir; Levdansky,Yevgen; Fritz, Brian R; Andrianova, Elizaveta A; Jain, Ruchi; Valkov,Eugene; Köhrer, Caroline; Moore, Melissa J
  3. Cell Reports. 2024, Apr 15; 43(4): 114098.
  1. 8.   PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer
  2. Torres-Ayuso, Pedro; Katerji,Meghri; Mehlich, Dawid; Lookingbill, Sophia A; Sabbasani, Venkata R; Liou, Hope; Casillas, Andrea L; Chauhan, Shailender S; Serwa, Remigiusz; Rubin,Maxine; Marusiak, Anna A; Swenson, Rolf E; Warfel, Noel A; Brognard,John
  3. Cell Chemical Biology. 2023, Nov 16;
  1. 9.   Reactive Oxygen Species-Sensitive Biodegradable Mesoporous Silica Nanoparticles Harboring TheraVac Elicit Tumor-Specific Immunity for Colon Tumor Treatment
  2. Huang,Yue; Nahar, Saifun; Alam, Md Masud; Hu, Shuo; McVicar,Dan; Yang,De
  3. ACS Nano. 2023, Oct 13;
  1. 10.   Perspectives on Advancing Countermeasures for Filovirus Disease: Report from a Multi-Sector Meeting
  2. Sprecher, Armand; Cross, Robert; Marzi, Andrea; Martins, Karen A; Wolfe, Daniel; Montgomery, Joel M; Spiropoulou, Christina F; Cihlar, Tomas; Ahuka-Mundeke, Steve; Nyhuis, Tara; Teicher, Carrie; Crozier,Ian; Strong, Jim; Kobinger, Gary; Woolsey, Courtney; Geisbert, Thomas W; Feldmann, Heinz; Muyembe, Jean-Jacques
  3. The Journal of Infectious Diseases. 2023, Aug 19;
  1. 11.   Evaluation of Nonmodified Wireframe DNA Origami for Acute Toxicity and Biodistribution in Mice
  2. Wamhoff, Eike-Christian; Knappe, Grant A; Burds, Aurora A; Du, Rebecca R; Neun,Barry; Difilippantonio,Simone; Sanders,Chelsea; Edmondson,Elijah; Matta,Jennifer; Dobrovolskaia,Marina; Bathe, Mark
  3. ACS Applied Bio Materials. 2023, Apr 11;
  1. 12.   Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition
  2. Chen, Wei-Hung; Kim, JungHyun; Bu, Wei; Board, Nathan L; Tsybovsky,Yaroslav; Wang,Yanmei; Hostal, Anna; Andrews, Sarah F; Gillespie, Rebecca A; Choe, Misook; Stephens, Tyler; Yang, Eun Sung; Pegu, Amarendra; Peterson, Caroline E; Fisher, Brian E; Mascola, John R; Pittaluga, Stefania; McDermott, Adrian B; Kanekiyo, Masaru; Joyce, M Gordon; Cohen, Jeffrey I
  3. Immunity. 2022, Nov 8; 55(11): 2135-2148.
  1. 13.   Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants
  2. Chen, Zhaochun; Zhang, Peng; Matsuoka, Yumiko; Tsybovsky,Yaroslav; West, Kamille; Santos, Celia; Boyd, Lisa F; Nguyen, Hanh; Pomerenke, Anna; Stephens,Tyler; Olia, Adam S; Zhang, Baoshan; De Giorgi, Valeria; Holbrook, Michael R; Gross, Robin; Postnikova, Elena; Garza, Nicole L; Johnson, Reed F; Margulies, David H; Kwong, Peter D; Alter, Harvey J; Buchholz, Ursula J; Lusso, Paolo; Farci, Patrizia
  3. Cell Reports. 2022, Sep 30; 41(5): 111528.
  1. 14.   The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next Steps
  2. Crozier,Ian; Britson, Kyla A; Wolfe, Daniel N; Klena, John D; Hensley, Lisa E; Lee, John S; Wolfraim, Larry A; Taylor, Kimberly L; Higgs, Elizabeth S; Montgomery, Joel M; Martins, Karen A
  3. Vaccines. 2022, Jul 29; 10(8):
  1. 15.   Gain-of-function mutations in ALPK1 cause an NF-?B-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome
  2. Kozycki, Christina Torres; Kodati, Shilpa; Huryn, Laryssa; Wang, Hongying; Warner, Blake M; Jani, Priyam; Hammoud, Dima; Abu-Asab, Mones S; Jittayasothorn, Yingyos; Mattapallil, Mary J; Tsai, Wanxia Li; Ullah, Ehsan; Zhou, Ping; Tian, Xiaoying; Soldatos, Ariane; Moutsopoulos, Niki; Kao-Hsieh, Marie; Heller, Theo; Cowen, Edward W; Lee, Chyi-Chia Richard; Toro, Camilo; Kalsi, Shelley; Khavandgar, Zohreh; Baer, Alan; Beach, Margaret; Long-Priel,Debra; Nehrebecky, Michele; Rosenzweig, Sofia; Romeo, Tina; Deuitch, Natalie; Brenchley, Laurie; Pelayo, Eileen; Zein, Wadih; Sen, Nida; Yang, Alexander H; Farley, Gary; Sweetser, David A; Briere, Lauren; Yang, Janine; de Oliveira Poswar, Fabiano; Schwartz, Ida; Silva Alves, Tamires; Dusser, Perrine; Koné-Paut, Isabelle; Touitou, Isabelle; Titah, Salah Mohamed; van Hagen, Petrus Martin; van Wijck, Rogier T A; van der Spek, Peter J; Yano, Hiromi; Benneche, Andreas; Apalset, Ellen M; Jansson, Ragnhild Wivestad; Caspi, Rachel R; Kuhns,Doug; Gadina, Massimo; Takada, Hidetoshi; Ida, Hiroaki; Nishikomori, Ryuta; Verrecchia, Elena; Sangiorgi, Eugenio; Manna, Raffaele; Brooks, Brian P; Sobrin, Lucia; Hufnagel, Robert; Beck, David; Shao, Feng; Ombrello, Amanda K; Aksentijevich, Ivona; Kastner, Daniel L
  3. Annals of the Rheumatic Diseases. 2022, Jul 22;
  1. 16.   Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2
  2. Fintzi, Jonathan; Bonnett,Tyler; Tebas, Pablo; Marconi, Vincent C; Levine, Corri B; El Sahly, Hana M; McLellan, Susan L F; Benson, Constance A; Rostad, Christina A; Ganesan, Anuradha; Huprikar, Nikhil; Frank, Maria G; Mularski, Richard A; Atmar, Robert L; Park, Pauline K; Short, William R; Beigel, John H; Mehta, Aneesh K; Sweeney, Daniel A
  3. Open forum infectious diseases. 2022, Jul; 9(7): ofac219.
  1. 17.   Stealth oxime ether lipid vesicles promote delivery of functional DsiRNA in human lung cancer A549 tumor bearing mouse xenografts
  2. Puri,Anu; Ibrahim, Faisal; O'Reilly Beringhs, André; Isemann, Camryn; Zakrevsky, Paul; Whittenburg, Abigail; Hargrove, Derek; Kanai,Tapan; Dillard, Rebecca S; de Val, Natalia; Nantz, Michael H; Lu, Xiuling; Shapiro,Bruce
  3. Nanomedicine : nanotechnology, biology, and medicine. 2022, Jun 04; 102572.
  1. 18.   Aminoflavone upregulates putative tumor suppressor miR-125b-2-3p to inhibit luminal A breast cancer stem cell-like properties
  2. Mavingire, Nicole; Campbell,Petreena; Liu, Tiantian; Wooten, Jonathan; Khan, Salma; Chen, Xin; Matthews, Jason; Wang, Charles; Brantley, Eileen
  3. Precision Clinical Medicine. 2022, Jun; 5(2): pbac008.
  1. 19.   Highly Efficient Autologous HIV-1 Isolation by Coculturing Macrophage With Enriched CD4+ T Cells From HIV-1 Patients
  2. Xufré, Cristina; González, Tanía; Leal, Lorna; Trubey, Charles M; Lifson,Jeffrey; Gatell, José María; Alcamí, José; Climent, Núria; García, Felipe; Sánchez-Palomino, Sonsoles
  3. Frontiers in Virology. 2022, Apr; 2
  1. 20.   Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses
  2. Milligan, Jacob C; Davis, Carl W; Yu, Xiaoying; Ilinykh, Philipp A; Huang, Kai; Halfmann, Peter J; Cross, Robert W; Borisevich, Viktoriya; Agans, Krystle N; Geisbert, Joan B; Chennareddy, Chakravarthy; Goff, Arthur J; Piper, Ashley E; Hui, Sean; Shaffer, Kelly C L; Buck, Tierra; Heinrich, Megan L; Branco, Luis M; Crozier,Ian; Holbrook, Michael R; Kuhn, Jens H; Kawaoka, Yoshihiro; Glass, Pamela J; Bukreyev, Alexander; Geisbert, Thomas W; Worwa, Gabriella; Ahmed, Rafi; Saphire, Erica Ollmann
  3. Cell. 2022, Mar 17; 185(6): 995-1007.e18.
  1. 21.   Molecular Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: Hazardous and More Hazardous Strains Behind the Coronavirus Disease 2019 Pandemic and Their Targeting by Drugs and Vaccines
  2. Tuli, Hardeep Singh; Sak, Katrin; Aggarwal,Poonam; Iqubal, Ashif; Upadhaya, Sushil K.; Kaur, Jagjit; Kaur, Ginpreet; Aggarwal, Diwakar
  3. Frontiers in Cellular and Infection Microbiology. 2021, Dec 14; 11
  1. 22.   Complex Tumor Spheroids, a Tissue-Mimicking Tumor Model, for Drug Discovery and Precision Medicine
  2. Kaur, Gurmeet; Evans, David M.; Teicher, Beverly A.; Coussens,Nathan
  3. SLAS Discovery. 2021, Nov 12;
  1. 23.   Whence CRIPTO: The Reemergence of an Oncofetal Factor in 'Wounds' That Fail to Heal
  2. Freeman, David W.; Sousa, Elisa Rodrigues; Karkampouna, Sofia; Zoni, Eugenio; Gray, Peter C.; Salomon,David; Kruithof-de Julio, Marianna; Spike, Benjamin T.
  3. International journal of molecular sciences. 2021, Sep; 22(18):
  1. 24.   Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection
  2. Tshiani Mbaya,Olivier; Mukumbayi, Philippe; Mulangu, Sabue
  3. Frontiers in Immunology. 2021, Aug 30; 12
  1. 25.   Controlled Organization of Inorganic Materials Using Biological Molecules for Activating Therapeutic Functionalities
  2. Chandler, Morgan; Minevich, Brian; Roark, Brandon; Viard,Mathias; Johnson, M Brittany; Rizvi, Mehedi H; Deaton, Thomas A; Kozlov, Seraphim; Panigaj, Martin; Tracy, Joseph B; Yingling, Yaroslava G; Gang, Oleg; Afonin, Kirill A
  3. ACS applied materials & interfaces. 2021, Aug 25; 13(33): 39030-39041.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel